Gammagard Liquid 10 % (Immunoglobulin (Human) SOLUTION) 10 %

GAMMAGARD LIQUID 10% is an intravenous immunoglobulin solution used to support immune function. This product, manufactured by Takeda Canada Inc., is available in various pack sizes for medical use.

Strength

10 %

Pack Size

10/25/50/100/200/300ML

Manufacturer / TM Owner

TAKEDA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

GAMMAGARD LIQUID 10% is primarily used to support the immune system in individuals with certain immune deficiencies. It may also be used to treat autoimmune disorders and other conditions where immune support is needed. This solution is administered intravenously and is designed to provide targeted immune support.

Side Effects

Common effects of GAMMAGARD LIQUID 10% may include mild to moderate reactions at the injection site, such as redness or swelling. Some individuals may experience flu-like symptoms, including headache, fatigue, or muscle aches. These effects are generally temporary and should be discussed with a healthcare provider.

Precautions & Warnings

GAMMAGARD LIQUID 10% should be handled with care and administered by a healthcare professional. It is important to follow proper storage and handling guidelines to maintain the integrity of the solution. Individuals with known allergies to immunoglobulin products should avoid using this medication.

Avoid Interactions

GAMMAGARD LIQUID 10% may interact with certain medications, including those that affect the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that affect the immune system should be used with caution.

Frequently Asked Questions

GAMMAGARD LIQUID 10% is used to support the immune system in individuals with immune deficiencies and certain autoimmune disorders.

GAMMAGARD LIQUID 10% is administered intravenously by a healthcare professional.

Common effects may include mild to moderate reactions at the injection site, such as redness or swelling, and flu-like symptoms.

Individuals with known allergies to immunoglobulin products should avoid using GAMMAGARD LIQUID 10%.

Yes, GAMMAGARD LIQUID 10% may interact with certain medications, especially those that affect the immune system.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.